Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Albury
Clinical trial register · Australia

Clinical Trials in Albury, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Exelixis5 Gilead Sciences3 Hoffmann-La Roche3 Regeneron Pharmaceuticals2 Bayer2
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Albury

53 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Biojiva LLC
Phase 1/2
152
Albury, Baulkham Hills, Hurstville, Sydney, East Melbourne, Rowville
2026-09-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
960
Albury, Sydney
2026-08-27
Recruiting
Bayer
Phase 1
130
Albury, Waratah, Malvern
2026-04-07
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
DrugsTiespectus·Eylea·Aflibercept
EyeBiotech Ltd.
Phase 2/3
960
Albury, Hurstville, Hurstville, Sydney, Launceston, Norwest, Parramatta, Strathfield, Sydney
2026-03-27
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Albury, Parramatta, Strathfield, East Melbourne
2026-03-09
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Albury, Hurstville, Parramatta, Sutherland, Sydney, East Melbourne, Rowville, Malvern
2025-11-10
Recruiting
Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NCT07055542Allergic Asthma, Thunderstorm Asthma, Seasonal Allergic Rhinitis, Grass Pollen Allergy
University of Melbourne
Not applicable
530
Albury, Box Hill, Clayton, Heidelberg, Melbourne, Parkville
2025-08-27
Recruiting
4D Molecular Therapeutics
Phase 3
480
Adelaide, Albury, Strathfield, Sydney
2025-07-22
Active, closed
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Albury, Hurstville, Parramatta, Sydney, Westmead, Birtinya, Adelaide
2025-02-11
Active, closed
Ocular Therapeutix, Inc.
Phase 3
825
Albury, Parramatta
2024-11-27
Recruiting
Bayer
Phase 1
104
Albury, Macquarie Park, Frankston, Malvern
2024-11-08
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Albury, Hurstville, Strathfield, Adelaide, East Melbourne
2024-10-30
Recruiting
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
69
Garran, Albury, Darlinghurst, St Leonards, Wahroonga, Chermside, South Brisbane, Adelaide
2024-08-14
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Albury, Bedford Park, St Albans, Traralgon
2024-08-07
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Sydney, Albury, Parramatta
2024-08-07
Active, closed
Annexon, Inc.
Phase 3
659
Albury, Parramatta, Strathfield, Sydney
2024-07-30
Recruiting
Inimmune Corporation
Phase 1
50
Albury, Bedford Park, Malvern
2024-07-01
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Albury, Waratah, Franskton, Melbourne, Murdoch
2024-02-21
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Albury, Liverpool, Parramatta, Strathfield, Sydney, Adelaide, Hobart, East Melbourne
2024-01-09
Recruiting
Omico
Phase 2
96
Albury, Coffs Harbour, Orange, Port Macquarie, Cairns, Rockhampton, Toowoomba, Townsville
2023-12-15
Active, closed
Incyte Corporation
Phase 2
63
Albury, Townsville, Woolloongabba, Box Hill, Clayton
2023-10-09
Active, closed
McMaster University
Phase 4
446
Albury, Blacktown, Bondi Junction, Hurstville, Lane Cove, Liverpool, Parramatta, Strathfield
2023-05-01
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Albury, Campbelltown, Camperdown, Gosford, New Lambton Heights, Saint Leonards, Wentworthville, Southport
2023-04-18
Active, closed
Gilead Sciences
Phase 2
400
Albury, Benowa, Adelaide, Nedlands
2023-02-21
Active, closed
Exelixis
Phase 3
317
Albury, Camperdown, Liverpool, Macquarie, Sydney, Waratah, Douglas, Elizabeth Vale
2023-01-01
Recruiting
Leiden University Medical Center
Phase 2
168
Albury, Camperdown, Kogarah, Newcastle, St Leonards, Wahroonga, Birtinya, South Brisbane
2022-11-10
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Active, closed
BioAtla, Inc.
Phase 1/2
320
Albury, Miranda, Adelaide
2022-08-03
Active, closed
Gilead Sciences
Phase 3
443
Albury, Kogarah, North Sydney, St Leonards, South Brisbane, Woolloongabba, Adelaide, Hobart
2022-07-25
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
East Melbourne, Albury, Sydney, Bendigo, St Albans
2022-06-30
Active, closed
IO Biotech
Phase 3
407
Albury, Westmead, Wollongong, Cairns, Bedford Park, Woodville South, Birtinya, Melbourne
2022-05-17
Active, closed
Australasian Gastro-Intestinal Trials Group
Not applicable
6
Albury, Bendigo, Box Hill, Epping, Fitzroy, Geelong, Melbourne, Saint Albans
2021-12-14
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Albury, Birtinya, Brisbane, Saint Leonards, Sydney
2021-12-14
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Active, closed
Gilead Sciences
Phase 3
603
Albury, Bowral, Darlinghurst, Birtinya, Greenslopes, Bedford Park, Hobart, Box Hill
2021-11-17
Active, closed
Boehringer Ingelheim
Phase 1
151
Albury, Darlinghurst, Douglas, Heidelberg
2021-10-18
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Albury, Campbelltown, Liverpool, Northmead, Port Macquarie, Wollstonecraft, Auchenflower, Brisbane
2021-08-27
Active, closed
Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT04969887Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm, MSI-H Solid Malignant Tumor
DrugsYervoy·Ipilimumab·Opdivo·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
240
Albury, Orange, Sydney, Waratah, Cairns, Douglas, Townsville, Adelaide
2021-08-03
Active, closed
Hoffmann-La Roche
Phase 3
451
Albury, Hurstville, Liverpool, Miranda, Sydney, Woolloongabba, East Melbourne, Rowville
2021-07-14
Recruiting
Takeda
Phase 2
160
Albury, Tweed Heads, Westmead, Douglas, Adelaide, Bedford Park, Box Hill, Geelong
2020-08-19
Recruiting
Nordic Lymphoma Group
Phase 3
300
Albury, Camperdown, Coffs Harbour, Concord, Cudgen, Garran, Hobart, Liverpool
2020-08-19
Active, closed
University of Sydney
Phase 3
1,100
Albury, Gosford, Newcastle, Nowra, Sydney, Wollongong, Brisbane, Herston
2020-03-31
Active, closed
Exelixis
Phase 3
855
Albury, Kogarah, North Ryde, Sydney, South Brisbane, Woolloongabba, Adelaide, North Adelaide
2019-06-25
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Albury, Coffs Harbour, Gosford, Kogarah, St Leonards, Wagga Wagga, Waratah, Westmead
2019-06-04
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Albury, Herston, Townsville, Fitzroy, Nedlands
2019-03-11
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Albury, Randwick, Woolloongabba, Kurralta Park, Melbourne
2019-02-08
Active, closed
Celgene
Phase 3
363
Albury, Blacktown, Concord, Kogarah, Nowra, Waratah, Wollongong, Auchenflower
2019-01-02
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Albury, Hurstville
2018-09-20
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Albury, Camperdown, Gosford, North Ryde, Randwick, St Albans
2017-09-05
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Albury, Tweed Heads, Wahroonga, Ashford, Ballarat, East Bentleigh, Malvern, Parkville
2016-12-22
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Albury, Camperdown
2016-06
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Albury, Elizabeth Vale, Kogarah, Port Macquarie, South Brisbane, St Leonards
2015-11-27
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
10,273
Albury, Coffs Harbour, Concord, Lismore, Merewether, Newcastle, Waratah, Herston
2006-04-07
Rows per page Showing 1–53 of 53
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/albury

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 53 of those studies with a site in Albury.

How many clinical trials are recruiting in Albury?

20 of the 53 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 33 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Albury), 53 studies
PhaseStudiesRecruitingShare
Phase 325547.2%
Phase 213724.5%
Phase 16411.3%
Phase 1/2427.5%
Not applicable213.8%
Phase 2/3213.8%
Phase 4101.9%

Most active sponsors

Lead sponsors with the most studies (Albury)
Lead sponsorStudiesRecruiting
Exelixis51
Gilead Sciences30
Hoffmann-La Roche31
Australasian Gastro-Intestinal Trials Group21
Bayer22
EyeBiotech Ltd.21
Regeneron Pharmaceuticals21
4D Molecular Therapeutics11
ADARx Pharmaceuticals, Inc.11
Annexon, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.